Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Combretastatin A4 is a microtubule-targeting agent that binds β-tubulin (Kd: 0.4 μM).
Description | Combretastatin A4 is a microtubule-targeting agent that binds β-tubulin (Kd: 0.4 μM). |
Targets&IC50 | β-tubulin:0.4 μM(Kd) |
Kinase Assay | Competitive binding assay using LC-MS/MS: Colchicine (1.2 μ M) is incubated with tubulin (1.3 mg/mL) in the incubation bu?er (80 mM PIPES, 2.0 mM MgCl2, 0.5 mM EGTA, pH 6.9) at 37℃ for 1 h. Varying concentrations (0.1 ? 125 μ M) of Combretastatin A4 are used to compete with colchicine originally bound to tubulin. After incubation, the ?ltrate is obtained. The ability of the analogue to inhibit the binding of colchicine is expressed as a percentage of control binding in the absence of any competitor. |
Cell Research | MDA-MB-231, A549, and HeLa cells are grown in DMEM medium (115 units/mL of penicillin G, 115 μg/mL of streptomycin, and 10% fetal bovine serum). Cells are seeded in 96-well plates (5000 cells/well) containing 50 μL of growth medium for 24 h. After medium removal, 100 μL of fresh medium containing individual analogue compounds at di?erent concentrations is added to each well and incubated at 37 ℃ for 72 h. After 24 h of culture, the cells are supplemented with 50 μL of analogue compounds dissolved in DMSO (less than 0.25% in each preparation). After 72 h of incubation, 20 μL of resazurin is added for 2 h before recording ?uorescence at 560 nm (excitation) and 590 nm (emission) using a Victor microtiter plate ?uorimeter. The IC50 is de?ned as the compound concentration required to inhibit cell proliferation by 50% in comparison with cells treated with the maximum amount of DMSO (0.25%) and considered as 100% viability.(Only for Reference) |
Synonyms | CA4, 康普瑞汀, Z)-3,4,5,4',-四甲氧基-3'-羟基二苯乙烯, CRC 87-09 |
Molecular Weight | 316.353 |
Formula | C18H20O5 |
CAS No. | 117048-59-6 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Ethanol: 31.6 mg/mL (100 mM)
DMSO: 31.6 mg/mL (100 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Combretastatin A4 117048-59-6 细胞骨架 Microtubule Associated inhibit CA4 Microtubule/Tubulin Combretastatin A-4 CRC 87-09 Inhibitor Combretastatin A 4 inhibitor